Nasdaq News

Chipotle Mexican Grill (NYSE: CMG) and Beyond Meat (NASDAQ: BYND) are as close as you can probably get to companies that have their own mantras. Chipotle's been waving the "food with integrity" banner for ages. Dive into the first line of Beyond Meat's mission statement, meanwhi

Latin America has almost twice the population of the U.S., and 25% more internet users, but it's way behind in e-commerce adoption. In 2019, the region's online spending was only 4.4% of total retail sales versus 10.9% for the U.S., even though both geographies have around 200

I've followed Veeva Systems (NYSE: VEEV), a provider of cloud-based services for life science companies, over the past few years. Its growth rate and wide moat impressed me, but the stock always seemed too hot to handle.

You've spent years in the workforce, diligently paying into the Social Security program. Unfortunately, though, that doesn't exempt you from potentially paying taxes on your benefits in retirement.

Any shortlist of leaders in the race to develop a coronavirus vaccine will definitely include AstraZeneca (NYSE: AZN). And Regeneron Pharmaceuticals (NASDAQ: REGN) will certainly rank highly on any list of the top companies developing potential treatments for COVID-19.

Data from Pew Research suggests that millennials overtook baby boomers in 2019 as the largest age demographic in the U.S., and people within this increasingly influential generation are just beginning to enter their prime spending years. With the rise of Robinhood and other app-

The energy sector is deeply out of favor, as oil and natural gas companies pull back in the face of depressed oil prices. But the different parts of the industry aren't impacted equally. Midstream players like Canada's Enbridge (NYSE: ENB) and U.S.-domiciled Enterprise Products

Moderna (NASDAQ: MRNA) hasn't even been publicly traded for two years, but shares have risen by leaps and bounds since the company held its initial public offering (IPO) on Dec. 7, 2018, when the stock was priced at just $23. Today, you can purchase one share of Moderna for roug

There have been more than 20 million coronavirus cases and 749,000 COVID-19-related deaths worldwide. The U.S. alone has recorded 5 million cases and 169,000 related deaths. Before life, and the economy, can return to normal, a safe and effective vaccine must be made widely avai

Tens of millions of Americans have lost their jobs in the course of the COVID-19 outbreak, so much so that the U.S. unemployment rate has been in double digit territory since April. But not everyone on unemployment has completely lost a job. Some employees are currently furlough

With the breakout of the COVID-19 pandemic earlier this year, the cruise industry is facing a historically tough challenge. As numerous countries imposed lockdowns and closed borders, cruise companies joined airlines in grounding their fleets as cancellations mounted with alarmi

This year has not been a good one for income investors. With the COVID-19 outbreak shutting down much of the global economy, many companies slashed their payouts to preserve cash. While investors experienced industrywide dividend destruction, the energy sector was among the har

Friday's upbeat retail data comes at a critical time since the market will get earnings reports from some notable retailers, including Walmart (WMT), Target (TGT) and and Home Depot (HD).

The stock market experienced one of its steepest declines less than five months ago. Many stocks have since recovered and are putting up impressive gains, but there's no guarantee that this recent rally will continue. The U.S. unemployment rate is still above 10%, state and loca

The stock market had a great run in the 2010s, but 2020 has already reminded us that crashes do happen -- and that they're pretty unpleasant. A sudden 30% drop in the value of your long-term savings can reverse years of contributions and investment growth, putting your retiremen

Gilead Sciences (NASDAQ: GILD) has been at the forefront of the coronavirus treatment space since the early days of the pandemic. During this past spring and early summer, the company donated almost a million doses of its antiviral medication, remdesivir, to the U.S. government

Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) are two of the bigger names in the cannabis industry. They're both facing similar challenges -- namely, how to keep growing amid rising competition while also getting closer to breakeven. Within the past 14 months, bot

Inovio Pharmaceuticals (NASDAQ: INO) has enjoyed a remarkable year so far by any standard. The biotech is in the thick of the race to develop a COVID-19 vaccine. It has made significant progress with its other pipeline candidates. Inovio's shares have skyrocketed close to 350%.

Which of Pfizer's (NYSE: PFE) products grab investors' attention the most? I'd put BNT162b2, the COVID-19 vaccine candidate that Pfizer is developing with BioNTech, high on the list. The company's top-selling drugs Ibrance and Eliquis would also certainly make the cut. Pneumoco

Former Indian Prime Minister Indira Gandhi once said, "Popularity is not a guarantee of quality." She was exactly right. And her statement is applicable to investing as much as it is anything else.